Clinical trial
Protective Role of Oxcarbazepine in Multiple Sclerosis
NCT02104661
Study timeline
Study start (unknown)2014-10-01Date precision: month
Registry last updated2018-04-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Multiple Sclerosisunresolved
Interventions
OxcarbazepineDRUG · verified · RxNorm: oxcarbazepine
PlaceboDRUG
Sponsors & collaborators
Queen Mary University of Londonlead sponsor
National Multiple Sclerosis Societycollaborator
Novartis Pharmaceuticalscollaborator
Barts & The London NHS Trustcollaborator
University College, Londoncollaborator
Royal Free Hospital NHS Foundation Trustcollaborator
Mid and South Essex NHS Foundation Trustcollaborator
St George's Healthcare NHS Trustcollaborator
Barnet and Chase Farm Hospitals NHS Trustcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02104661 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.